NIH Weekly Funding Opportunities and Policy Notices

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Wednesday, March 14, 2018 - 7:39am
Funding Opportunity PAR-18-714 from the NIH Guide for Grants and Contracts. The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.
Notice of Change to Applications Types for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)"
Wednesday, March 14, 2018 - 7:27am
Notice NOT-AT-18-010 from the NIH Guide for Grants and Contracts
Notice of Change to Applications Types for PAR-18-662, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)"
Wednesday, March 14, 2018 - 7:22am
Notice NOT-AT-18-011 from the NIH Guide for Grants and Contracts
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed)
Wednesday, March 14, 2018 - 1:35am
Funding Opportunity PAR-18-700 from the NIH Guide for Grants and Contracts. The purpose of the NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) program is to support a comprehensive, rigorous biomedical research training, and dissertation research leading to a research doctorate (i.e., Ph.D.) in the biomedical, behavioral, or clinical sciences.
Notice of NIAMS Withdrawal from Participation in PAR-18-289 "Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)"
Tuesday, March 13, 2018 - 10:37am
Notice NOT-AR-18-020 from the NIH Guide for Grants and Contracts
Notice of NIAMS Withdrawal from Participation in PAR-18-288 "Surgical Disparities Research (R01 Clinical Trial Optional)"
Tuesday, March 13, 2018 - 10:21am
Notice NOT-AR-18-019 from the NIH Guide for Grants and Contracts
Notice of NIEHS' Participation in PA-18-676, "Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations - An ORWH FY18 Administrative Supplement (Admin Supp Clinical Trial Optional)"
Tuesday, March 13, 2018 - 10:16am
Notice NOT-ES-18-008 from the NIH Guide for Grants and Contracts
Correction to Fellowship Administrative Supplement Package Associated with PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements"
Tuesday, March 13, 2018 - 9:51am
Notice NOT-OD-18-151 from the NIH Guide for Grants and Contracts
Notice of NIDCR's Participation in PA-17-460 "Biology of Lung, and Head and Neck Preneoplasias (R21- Clinical Trial Not Allowed)"
Tuesday, March 13, 2018 - 9:46am
Notice NOT-DE-18-013 from the NIH Guide for Grants and Contracts
Notice of NIDCR's Participation in PA-17-459 "Biology of Lung, and Head and Neck Preneoplasias (R01- Clinical Trial Not Allowed)"
Tuesday, March 13, 2018 - 9:38am
Notice NOT-DE-18-012 from the NIH Guide for Grants and Contracts
Notice of Pre-Application Webinar for: RFA-AR-19-001, NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed), and RFA-AR-19-002, "NIAMS Musculoskeletal Biology and Medicine"
Tuesday, March 13, 2018 - 8:58am
Notice NOT-AR-19-008 from the NIH Guide for Grants and Contracts
Notice to Clarify that Revision Applications are Prohibited under PAR-18-663 "Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)"
Tuesday, March 13, 2018 - 8:46am
Notice NOT-AT-18-007 from the NIH Guide for Grants and Contracts
FY2018 - AHRQ to begin allowing Facilities and Administrative (F and A) costs of 8% MTDC for consortia located at foreign institutions
Tuesday, March 13, 2018 - 8:32am
Notice NOT-HS-18-006 from the NIH Guide for Grants and Contracts
Update in Purpose Section of PAR-15-187 - Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Program
Tuesday, March 13, 2018 - 8:30am
Notice NOT-FD-18-007 from the NIH Guide for Grants and Contracts
Notice of NIDA's participation in PAR-18-694 "Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 - Clinical Trial Optional)"
Tuesday, March 13, 2018 - 6:35am
Notice NOT-DA-18-007 from the NIH Guide for Grants and Contracts
Additional Awards Eligible for PA-18-586 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Tuesday, March 13, 2018 - 6:27am
Notice NOT-OD-18-147 from the NIH Guide for Grants and Contracts
Notice of Correction to PAR-18-656 "NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Monday, March 12, 2018 - 11:47pm
Notice NOT-DE-18-011 from the NIH Guide for Grants and Contracts
FDA Drug Residue Prevention Program (U18)
Monday, March 12, 2018 - 9:31am
Funding Opportunity RFA-FD-18-006 from the NIH Guide for Grants and Contracts. The intended outcome of this program is to advance efforts to improve and develop state drug residue prevention programs. It is necessary to provide assistance to state drug residue programs that need a stronger foundation to promote the prevention of illegal drug residues in animal derived foods through educational outreach and training. This program is intended to ensure drug residue prevention programs are developed to protect consumer exposure to drug residues in the edible products of food animals and support activities related to drug residue prevention. In addition, these awards will assist state agencies to better direct their programs to reduce the outcomes of illegal drug residues in animal derived foods. This cooperative agreement program (CAP) will focus on outreach, education and training. In addition, grantees will focus on performing targeted on-site assessments related to drug residue violations and best practice visits to industry and individuals to communicate proper drug use and promote effective management practices for drug residue prevention.
Notice of NIDA Participation in RFA-OD-18-004 "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)"
Monday, March 12, 2018 - 8:05am
Notice NOT-DA-18-009 from the NIH Guide for Grants and Contracts
Notice of NCCIH Participation in PA-18-676 "Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp Clinical Trial Optional)"
Monday, March 12, 2018 - 7:51am
Notice NOT-AT-18-008 from the NIH Guide for Grants and Contracts

Pages